Acetaminophen Pregnancy Risks Include Autism Spectrum Disorders: Study

Exposure to the side effects of acetaminophen in the womb could double the risk of hyperactivity and increase the risk of other neuropsychological and behavioral disorders, such as autism, according to the findings of new research. 

In a study published late last month in the International Journal of Epidemiology, Spanish researchers report that pregnant women who used acetaminophen, the active ingredient in Tylenol, had double the risk of giving birth to a child with hyperactivity and impulsivity symptoms.

Researchers reviewed data on 2,644 mother-child pairs in a birth cohort study during pregnancy, evaluating about 88% of the children when they were one year old, and about 80% when they turned five.

Tylenol Autism Lawsuit

Does your child have Austism from Tylenol Exposure?

Side effects of Tylenol may cause autism and ADHD among children exposed during pregnancy. Find out if your family may be eligible for a Tylenol autism or ADHD settlement.

Learn More See If You Qualify For Compensation

Ever-use of acetaminophen, meaning the mother at least used it once during pregnancy, was linked to a 41% increase in hyperactivity/impulsivity symptoms in children, and increased the risk of an autism diagnosis as well. In addition, frequent use of the painkiller increased the risk of hyperactivity and impulsivity to more than double, according to the findings.

“Paracetamol (the name for acetaminophen in Europe) could be harmful to neurodevelopment for several reasons,” Co-author Dr. Jordi Julvez said in a press release. “First of all, it relieves pain by acting on cannabinoid receptors in the brain. Since these receptors normally help determine how neurons mature and connect with one another paracetemol could alter these important processes. It can also affect the development of the immune system, or be directly toxic to some fetuses that may not have the same capacity as an adult to metabolize this drug, or by creating oxidative stress.”

In February, researchers from Norway published a study in the same journal warning that exposure to Tylenol during pregnancy and shortly after birth could result in an increased risk of asthma.

The researchers in the latest study noted that the autism risks were more pronounced in boys. Some speculated that the male brain may be more vulnerable to harmful exposures during development.

Although most concerns assume Tylenol is safe, acetaminophen products have been linked to a number of potential health risks. The pain killer has been identified as a leading cause for liver injury in the United States, causing an estimated 50,000 emergency room visits each year, including 25,000 hospitalizations and over 450 deaths annually. In addition, use of the medication has been linked to a risk of dangerous skin reactions, like Stephens-Johnson Syndrome.

In recent years, efforts have been ramped up to bring the risk of acetaminophen overdoses to the public’s attention and to reduce the amount of liver injury cases linked to the popular analgesic, which is also found in other pain killers and a number of cold medications.

In 2011, Johnson & Johnson lowered the maximum recommended dosage on Tylenol and other acetaminophen-based products from 4,000 mg per day to 3,000 mg per day. However, the drug maker now faces a number of Tylenol liver failure lawsuits, which involve allegations that important safety information from the public for decades.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S.
Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S. (Posted today)

A recently filed Depo-Provera lawsuit questions why Pfizer updated the drug label in Europe, to warn about the risk of meningioma brain tumors, but failed to provide the same Depo-Provera warnings to U.S. consumers and doctors.

Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week
Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week (Posted 2 days ago)

U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.